Denosumab Increases Cardiovascular Risk in Dialysis-Dependent Patients
Denosumab has greater preventive effect on fractures, but increased risk for MACE compared with oral bisphosphonates
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.